Search results for

As the number of people who inject drugs and share needles has soared, the rate of infection with hep C has climbed, too. Yet many drug treatment patients aren't tested for the liver-damaging virus.

Trump administration efforts to undo Obama-era health insurance rules have helped increase sales of limited health plans that cost consumers less than traditional coverage.

Doctors say the machine that helps some people with sleep apnea keep their airway open at night won't be enough to help an ill COVID-19 patient breathe and could spread the coronavirus to bystanders.

Even many symptomatic patients and exposed health workers who are able to get a COVID-19 test must wait nearly a week to get results. Others get results in hours. Here's why it varies so much.

Molecular diagnostics are at the frontier of medical science. But along with precise information about health, the tests raise billing questions that can create a minefield for patients.

The specialized swabs required for coronavirus tests are quite different from your standard Q-tips. And U.S. hospitals are running out of them, creating another delay in efforts to expand testing.

Biologic drugs, often made with the help of living organisms, are especially lucrative because they have scant competition from biosimilars, drugs akin to generics. It's a different story in Europe.

A Senate hearing on Tuesday featuring pharmaceutical executives will tackle many issues raised in the historic Kefauver hearings, which led to tougher drug regulation. High prices remain a concern.

The Trump administration's plan to force some Medicaid recipients to work to maintain benefits took another hit Wednesday when a U.S. district judge blocked such work rules in Kentucky and Arkansas.

Some states have begun using Medicare reimbursement rates to recalibrate how they pay hospitals. If the gamble pays off, more private-sector employers could start doing the same thing.